A Thank You Message from the Course Directors
Rome, March 2026
Dear Friends and Colleagues,
As we came to the conclusion of CILR & AI 2026, we would like to keep the momentum reflecting on these extraordinary days spent together.
This edition of CILR & AI has been a remarkable success, and one of which we can all be truly proud.
We welcomed more than 1,050 delegates from over 60 countries, supported by an outstanding faculty of 89 distinguished experts, all united by a common commitment to excellence in robotic and minimally invasive surgery.
Such an achievement is never the result of individual efforts. It is the product of teamwork, dedication, and a shared vision.
Our sincere gratitude goes to everyone who contributed to making this meeting possible: the entire team of the Regina Elena National Cancer Institute, the members of our International Selection Committee, the faculty, the moderators, the surgeons, and the exceptional Fedra Congressi team, whose professionalism and commitment have accompanied us throughout this journey.
The cornerstone of CILR & AI remains its Live Surgery Program. This year, we had the privilege of witnessing 38 highly complex surgical procedures, many of them facing rare diseases and particularly challenging cases. These operations are not only the witness of technical mastery, courage, judgment, but also the rational support to educational value of live surgery itself. Perioperative outcomes reported below are the proof of outstanding surgical quality of our invited surgeons.
Equally important was the Semi-Live Session, which has become an integral component of our meeting since its introduction in 2018. Through carefully selected cases performed throughout the year, this format continues to offer unique educational value, focusing attention on key aspects of surgery in a restricted time frame, therefore completing the educational value of a live surgery-only event. Thanks to the International Selection Committee composed of 14 esteemed colleagues, who selected 28 videos through a blinded reviewing process.
Our scientific agenda was further strengthened by five outstanding panel discussions dedicated to some of the most relevant topics in contemporary urology: Radical Prostatectomy, Partial Nephrectomy, Reconstructive Surgery, Artificial Intelligence, and Emerging Technologies in Prostate Cancer. These sessions highlighted not only where we stand today, but also where our specialty is heading in the years to come.
Beyond the scientific program, CILR has always been about something more: friendship, collaboration, mentorship, and the creation of an international community united by a passion for innovation and patient care.
And there could have been no better setting for this gathering than Rome, a city that continues to inspire us with its history, culture, beauty, and timeless spirit.
As we return to our institutions, our operating rooms, and our patients, we hope that each of us takes home not only new knowledge and new skills, but also renewed enthusiasm for the work we do every day.
We thank you for your participation, your trust, your friendship, and your contribution to the success of 2026 CILR & AI, and we look forward to welcoming you again in Rome for an inspiring and successful edition of CILR on June 3-4-5, 2027.
Vito and Giuseppe